MESP2
Basic information
Region (hg38): 15:89760591-89778754
Links
Phenotypes
GenCC
Source:
- spondylocostal dysostosis 2, autosomal recessive (Definitive), mode of inheritance: AR
- spondylocostal dysostosis 2, autosomal recessive (Strong), mode of inheritance: AR
- autosomal recessive spondylocostal dysostosis (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spondylocostal dysostosis 2, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 15214000; 15122512; 18485326; 20301771 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (30 variants)
- Spondylocostal dysostosis 2, autosomal recessive (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MESP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 244 | 249 | ||||
missense | 75 | 84 | ||||
nonsense | 18 | 10 | 35 | |||
start loss | 1 | |||||
frameshift | 14 | 12 | 29 | |||
inframe indel | 14 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 11 | 16 | 31 | |||
Total | 32 | 13 | 114 | 269 | 15 |
Highest pathogenic variant AF is 0.000171
Variants in MESP2
This is a list of pathogenic ClinVar variants found in the MESP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-89776082-T-C | Benign (Jun 20, 2021) | |||
15-89776088-G-A | Benign (Jun 20, 2021) | |||
15-89776347-G-A | not specified • Spondylocostal dysostosis | Likely benign (Jun 14, 2016) | ||
15-89776358-A-G | not specified | Uncertain significance (Nov 16, 2023) | ||
15-89776361-GC-G | Pathogenic (Mar 03, 2022) | |||
15-89776363-C-T | Likely benign (Sep 27, 2023) | |||
15-89776368-C-A | Spondylocostal dysostosis 2, autosomal recessive | Pathogenic/Likely pathogenic (Apr 12, 2023) | ||
15-89776368-CGCCTCCTCCGCAGA-C | Pathogenic (Nov 24, 2021) | |||
15-89776368-C-CGCCTCCTCCGCAGA | Pathogenic (Dec 21, 2021) | |||
15-89776375-T-A | Spondylocostal dysostosis 2, autosomal recessive | Likely benign (Jul 11, 2023) | ||
15-89776377-C-A | Uncertain significance (Feb 04, 2022) | |||
15-89776378-G-A | Likely benign (Apr 05, 2023) | |||
15-89776378-G-T | Likely benign (Mar 26, 2022) | |||
15-89776381-G-A | Likely benign (Dec 17, 2021) | |||
15-89776387-C-T | Likely benign (Jun 13, 2022) | |||
15-89776390-C-A | Likely benign (Jan 30, 2024) | |||
15-89776393-C-G | Likely benign (Nov 17, 2023) | |||
15-89776397-G-T | Uncertain significance (Oct 01, 2022) | |||
15-89776400-C-G | Inborn genetic diseases | Uncertain significance (Nov 21, 2023) | ||
15-89776404-G-A | Pathogenic (Nov 07, 2021) | |||
15-89776405-G-A | Spondylocostal dysostosis 2, autosomal recessive | Likely pathogenic (Jun 27, 2017) | ||
15-89776405-GA-G | Spondylocostal dysostosis 2, autosomal recessive | Pathogenic (Oct 24, 2023) | ||
15-89776415-C-T | Pathogenic (Feb 08, 2023) | |||
15-89776420-C-A | Likely benign (Dec 04, 2022) | |||
15-89776424-G-A | Spondylocostal dysostosis 2, autosomal recessive • MESP2-related disorder | Likely benign (Jan 25, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MESP2 | protein_coding | protein_coding | ENST00000341735 | 2 | 18161 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000311 | 0.563 | 124731 | 0 | 20 | 124751 | 0.0000802 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.187 | 204 | 212 | 0.964 | 0.0000119 | 2438 |
Missense in Polyphen | 34 | 38.671 | 0.87922 | 550 | ||
Synonymous | -0.0161 | 103 | 103 | 1.00 | 0.00000656 | 873 |
Loss of Function | 0.834 | 10 | 13.3 | 0.753 | 5.88e-7 | 132 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000672 | 0.0000646 |
Ashkenazi Jewish | 0.0000995 | 0.0000993 |
East Asian | 0.000569 | 0.000557 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000660 | 0.0000618 |
Middle Eastern | 0.000569 | 0.000557 |
South Asian | 0.0000332 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor with important role in somitogenesis. Defines the rostrocaudal patterning of the somite by participating in distinct Notch pathways. Regulates also the FGF signaling pathway. Specifies the rostral half of the somites. Generates rostro-caudal polarity of somites by down-regulating in the presumptive rostral domain DLL1, a Notch ligand. Participates in the segment border formation by activating in the anterior presomitic mesoderm LFNG, a negative regulator of DLL1-Notch signaling. Acts as a strong suppressor of Notch activity. Together with MESP1 is involved in the epithelialization of somitic mesoderm and in the development of cardiac mesoderm.;
- Disease
- DISEASE: Spondylocostal dysostosis 2, autosomal recessive (SCDO2) [MIM:608681]: A condition of variable severity associated with vertebral and rib segmentation defects. The main skeletal malformations include fusion of vertebrae, hemivertebrae, fusion of certain ribs, and other rib malformations. Deformity of the chest and spine (severe scoliosis, kyphoscoliosis and lordosis) is a natural consequence of the malformation and leads to a dwarf- like appearance. As the thorax is small, infants frequently have respiratory insufficiency and repeated respiratory infections resulting in life-threatening complications in the first year of life. {ECO:0000269|PubMed:15122512}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Cardiac Progenitor Differentiation;Gene regulatory network modelling somitogenesis
(Consensus)
Recessive Scores
- pRec
- 0.141
Haploinsufficiency Scores
- pHI
- 0.108
- hipred
- N
- hipred_score
- 0.187
- ghis
- 0.437
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.125
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mesp2
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; skeleton phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); muscle phenotype; cellular phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- mespab
- Affected structure
- determination of heart left/right asymmetry
- Phenotype tag
- abnormal
- Phenotype quality
- decreased efficacy
Gene ontology
- Biological process
- mesoderm formation;somitogenesis;heart morphogenesis;Notch signaling pathway;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;protein dimerization activity